Allogeneic, or “off-the-shelf,” cell therapies promise something different: one donor’s cells banked and shipped on demand to ...

Of particular interest were novel therapies for EGFR exon 20 insertion mutations in non-small cell lung cancer, which ...

A newly identified weakness in “zombie” cells may open the door to more precise cancer treatments by turning their own ...

Among the challenges in treating disease, including cancer, is wiping out malignancies, infection, contaminants or other pathologies, without destroying healthy tissue.

When activated by its target, the newly characterized molecule rips the genome apart, a lethal move that researchers can ...

A new strategy to strengthen the body’s natural immune defenses against cancer is showing early promise, particularly for patients with limited treatment options.

Scientists have developed a strategy to boost the cancer-fighting power of natural killer (NK) cells, part of the immune ...

Scientists at UCLA have developed an "off-the-shelf" cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs. In a mouse study, ...

The first clinical trial to test the tumour-fighting power of a stem-cell-like class of long-lived immune cells suggests that ...

Using a powerful single-molecule imaging method they developed, a Broad Institute research team has unveiled a dynamic view ...